Funding for this research was provided by:
Forskningsrådet i Sydöstra Sverige (752041)
Futurum - Akademin för Hälsa och Vård, Region Jönköpings läns (670161)
Article History
Received: 14 April 2020
Accepted: 5 October 2020
First Online: 16 October 2020
Ethics approval and consent to participate
: This study was conducted in keeping with principles for research ethics, including informed verbal consent by all participating team members and protection of the integrity and dignity of individuals []. It includes no individual data from identifiable patients, only aggregate data from the health systems. The Ethical Review Committee in Linköping approved informed verbal consent by all participating team members. The study was approved by the Regional Ethical Review Committee in Linköping, Sweden. The reference number is 2016/486–31; date of approval 22 February 2017.
: Not applicable.
: Two of the co-authors have been reimbursed by Merck Sharpe & Dohme Bayer AB Sweden (JB, HK) and Actavis (JB) for running educational programmes and giving lectures. The other co-authors have stated that they have no conflicts of interest in connection with this manuscript.